Affluent Medical S.A.
AFME.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €53,117 | €51,686 | €56,246 |
| - Cash | €5,338 | €1,229 | €915 | €1,658 |
| + Debt | €21,105 | €16,329 | €17,501 | €17,134 |
| Enterprise Value | – | €68,217 | €68,272 | €71,722 |
| Revenue | €577 | €4,118 | €661 | €634 |
| % Growth | -86% | 523% | 4.3% | – |
| Gross Profit | -€1,142 | -€3,303 | -€440 | -€613 |
| % Margin | -197.9% | -80.2% | -66.6% | -96.7% |
| EBITDA | -€8,106 | -€5,177 | -€8,266 | -€6,945 |
| % Margin | -1,404.9% | -125.7% | -1,250.5% | -1,095.4% |
| Net Income | -€9,372 | -€5,371 | -€9,368 | -€7,673 |
| % Margin | -1,624.3% | -130.4% | -1,417.2% | -1,210.3% |
| EPS Diluted | -0.24 | -0.14 | -0.29 | -0.25 |
| % Growth | -71.4% | 51.7% | -16% | – |
| Operating Cash Flow | -€6,740 | -€7,622 | -€3,810 | -€3,523 |
| Capital Expenditures | -€105 | €64 | -€64 | -€150 |
| Free Cash Flow | -€6,845 | -€7,558 | -€3,874 | -€3,673 |